GLARITUS CART 10

About

Glaritus Cartridge 10 contains Insulin Glargine, a long-acting human insulin analog used for the treatment of type 1 and type 2 diabetes mellitus. Insulin Glargine is designed to provide a relatively constant glucose-lowering effect over 24 hours with no pronounced peak, mimicking the basal insulin secretion of a healthy pancreas. This sustained action helps maintain stable blood glucose levels between meals and overnight, significantly reducing the risk of nocturnal hypoglycemia compared to intermediate-acting insulins. It works by binding to insulin receptors on cells, facilitating glucose uptake by muscle and adipose tissue, and inhibiting glucose production by the liver. Glaritus Cartridge is intended for subcutaneous injection using an insulin pen device, providing flexible once-daily dosing.

Uses

• Treatment of type 1 diabetes mellitus in adults and children.
• Treatment of type 2 diabetes mellitus in adults.
• To provide basal insulin requirements.
• To achieve long-term glycemic control.

Directions For Use

Inject subcutaneously once daily at the same time each day, as directed by your healthcare provider.

Benefits

• Provides consistent, long-lasting blood sugar control.
• Reduces the risk of nocturnal hypoglycemia.
• Offers flexible once-daily dosing.
• Helps achieve target HbA1c levels.
• Mimics natural basal insulin secretion.
• Improves overall quality of life for diabetic patients.

Side Effects

• Hypoglycemia (low blood sugar)
• Injection site reactions (pain, redness, swelling)
• Lipodystrophy (fat atrophy or hypertrophy at injection site)
• Allergic reactions (rare, but serious)
• Weight gain
• Peripheral edema
• Pruritus
• Rash
• Urticaria
• Muscle cramps
• Visual disturbances (transient)
• Antibody formation

Safety Measures

• Alcohol - Alcohol can lower blood sugar and increase the risk of hypoglycemia; consume with extreme caution.
• Pregnancy - Consult a doctor; insulin is generally preferred for diabetes management during pregnancy.
• Breastfeeding - Consult a doctor; insulin is generally considered safe during breastfeeding, but monitoring is key.
• Liver - Dosage adjustments may be required in patients with liver impairment due to altered insulin metabolism.
• Kidney - Dosage adjustments may be required in patients with kidney impairment due to altered insulin clearance.
• Lung - Generally safe for use in patients with lung conditions; no specific precautions are usually needed.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.